Inventor · disambiguated record
Susana Del Rio Gancedo
Also filed as: DEL RIO GANCEDO SUSANA
12 granted patents·6 pending applications·33 citations·filing 2014–2025
87Inventor score
Files withREYNOLDS TOBACCO CO R4BECKLEY PSYTECH LTD3RENEO PHARMACEUTICALS INC3ESCAPE BIO INC2INFINITY PHARMACEUTICALS INC2
Top patents by PatentIndex Score
18 records- 0194US10508096B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2017·Granted Dec 17, 2019·12 cites·15 claims
- 0293US11773063B1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2022·Granted Oct 3, 2023·7 cites·10 claims
- 0388US11267795B2Crystalline PPAR-delta agonistRENEO PHARMACEUTICALS INC·Filed 2021·Granted Mar 8, 2022·4 cites·16 claims
- 0483US12209073B2Polymorphs of a dihydroorotate dehydrogenase (DHOD) inhibitorKIORA PHARMACEUTICALS GMBH·Filed 2023·Granted Jan 28, 2025·2 cites·20 claims
- 0583US10973803B2Sodium salt of N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1H-pyrazole-3-sulfonamideINFLAZOME LTD·Filed 2020·Granted Apr 13, 2021·1 cites·32 claims
- 0683US2025074886A1Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2024·Application pending·0 cites
- 0782US11225468B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2019·Granted Jan 18, 2022·3 cites·9 claims
- 0882US9481667B2Salts and solid forms of isoquinolinones and composition comprising and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2014·Granted Nov 1, 2016·4 cites·35 claims
- 0975US12180179B2Nicotine salts, co-crystals, and salt co-crystal complexesREYNOLDS TOBACCO CO R·Filed 2021·Granted Dec 31, 2024·0 cites·21 claims
- 1070US2024002356A1Crystalline ppar-delta agonistRENEO PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1169US12264131B2Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2023·Granted Apr 1, 2025·0 cites·20 claims
- 1267US11713301B2Crystalline PPARδ agonistRENEO PHARMACEUTICALS INC·Filed 2022·Granted Aug 1, 2023·0 cites·19 claims
- 1366US2025263372A1Pharmaceutically acceptable salts and compositions thereofBECKLEY PSYTECH LTD·Filed 2025·Application pending·0 cites
- 1459US12152029B2Crystalline forms of a MAGL inhibitorH LUNDBECK AS·Filed 2022·Granted Nov 26, 2024·0 cites·25 claims
- 1557US2023339967A1Solid forms of an s1p-receptor modulatorESCAPE BIO INC·Filed 2022·Application pending·0 cites
- 1655US2021315862A1Sodium Salt Of N-((1,2,3,5,6,7-Hexahydro-S-Indacen-4-Yl) Carbamoyl) -1 -Isopropyl-1 H-Pyrazole-3-SulfonamideINFLAZOME LTD·Filed 2021·Application pending·0 cites
- 1754US11535632B2Solid forms of an S1P-receptor modulatorESCAPE BIO INC·Filed 2020·Granted Dec 27, 2022·0 cites·3 claims
- 1844US2016024051A1Salts and solid forms of isoquinolinones and composition comprising and methods of using the sameINFINITY PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Susana Del Rio Gancedo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →